Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $83.86 USD
Change Today +0.37 / 0.44%
Volume 3.1M
ESRX On Other Exchanges
Symbol
Exchange
ESRX is not on other exchanges.
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

express scripts holding co (ESRX) Key Developments

Express Scripts Holding Mulls Acquisitions

Express Scripts Holding Company (NasdaqGS:ESRX) is seeking acquisitions. George Paz, Chairman and Chief Executive Officer of Express Scripts Holding, said, “So whether it be through share repurchases or through accretive acquisitions, our focus is to manage your capital, in a diligent manner to maximize return.”

Express Scripts Holding Company Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ending December 31, 2015; Provides Earnings Guidance for the Third Quarter of 2015

Express Scripts Holding Company reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenues of $25,454.2 million against $25,111.0 million for the same period last year. Operating income was $1,132.7 million against $966 million for the same period last year. Income before income taxes was $1,006.4 million against $841.6 million for the same period last year. Net income attributable to the company was $600.1 million or $0.88 per diluted share against $515.2 million or $0.67 per diluted share for the same period last year. EBITDA attributable to the company, as reported was $1,714.9 million against $1,516.6 million a year ago. Adjusted EBITDA, attributable to the company was $1,794.5 million against $1,735.2 million a year ago. Adjusted EBITDA attributable to company per adjusted claim was $5.59 compared to $5.35 a year ago. Adjusted net income attributable to the company was $979.1 million or $1.44 per diluted share against $939.4 million or $1.23 per diluted share for the same period last year. For the six months, the company reported revenues of $50,353.8 million against $48,796.0 million for the same period last year. Operating income was $1,959.3 million against $1,675.2 million for the same period last year. Income before income taxes was $1,721.9 million against $1,437.4 million for the same period last year. Net income attributable to the company was $1,041.2 million or $1.47 per diluted share against $843.5 million or $1.09 per diluted share for the same period last year. Net cash provided by operating activities was $1,181.3 million against $1,189.5 million for the same period last year. Purchases of property and equipment were $107.1 million against $208.8 million for the same period last year. EBITDA attributable to the company, as reported was $3,092.2 million against $2,772.7 million a year ago. Adjusted EBITDA, attributable to the company was $3,306.6 million against $3,206.2 million a year ago. Adjusted EBITDA attributable to company per adjusted claim was $5.26 compared to $4.97 a year ago. Adjusted net income attributable to the company was $1,790.2 million or $2.53 per diluted share against $1,718.6 million or $2.12 per diluted share for the same period last year. For the year ending December 31, 2015, the company provided adjusted earnings per share attributable to the company in the range of $5.46 to $5.54 compared to previous guidance in the range of $5.37 to $5.47. Adjusted EBITDA is expected to be in the range of $6,960 million to $7,120 million compared to previous guidance of $6,925 million to $7,125 million. Adjusted EBITDA per adjusted claim is expected to be in the range of $5.30 to $5.50 compared to previous guidance of $5.25 to $5.45. Cash flow from operations is expected to be in the range of $4,500 million to $5,000 million compared to previous guidance of $4,500 million to $5,000 million. Effective income tax rate is expected to be in range of 37.5% to 37.7% compared to previous guidance in the range of 37.3% to 37.7%. Capital expenditure is expected in the range of $300 million to $350 million compared to previous guidance in the range of $300 million to $400 million. For the third quarter of 2015, the company expects adjusted claims in range of $320 million to $340 million and adjusted earnings per diluted share in range of $1.41 to $1.45.

Keith J. Ebling to Leave Express Scripts Holding Company as Executive Vice President and General Counsel

On July 24, 2015, Express Scripts Holding Company announced that Keith J. Ebling will be leaving the company to pursue other interests and no longer serves in the role of Executive Vice President and General Counsel, but remains employed with the company for an indeterminate period of time in order to facilitate a smooth and orderly transition.

Express Scripts Holding Company to Report Q2, 2015 Results on Jul 28, 2015

Express Scripts Holding Company announced that they will report Q2, 2015 results After-Market on Jul 28, 2015

Express Scripts Holding Company, Q2 2015 Earnings Call, Jul 29, 2015

Express Scripts Holding Company, Q2 2015 Earnings Call, Jul 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESRX:US $83.86 USD +0.37

ESRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $115.18 USD +1.62
Anthem Inc $142.95 USD +2.48
Cardinal Health Inc $81.15 USD -0.50
Kroger Co/The $34.57 USD -0.08
Walgreens Boots Alliance Inc $88.26 USD +0.43
View Industry Companies
 

Industry Analysis

ESRX

Industry Average

Valuation ESRX Industry Range
Price/Earnings 27.4x
Price/Sales 0.6x
Price/Book 3.6x
Price/Cash Flow 25.6x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXPRESS SCRIPTS HOLDING CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.